Posttreatment plasma transforming growth factor beta 1 ( TGF-beta 1) level predicts for late morbidity in patients with advanced head and neck cancer / D. Feltl ... [et al.]. Neoplasma Vol. 52, no. 5 (2005), p. 393-397